Efficacy of Δ
aging
cannabidiol
cognition
endocannabinoid system
Δ9-tetrahydrocannabinol
Journal
Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824
Informations de publication
Date de publication:
2021
2021
Historique:
received:
01
06
2021
accepted:
06
08
2021
entrez:
16
9
2021
pubmed:
17
9
2021
medline:
17
9
2021
Statut:
epublish
Résumé
Decline in cognitive performance, an aspect of the normal aging process, is influenced by the endocannabinoid system (ECS). Cannabinoid receptor 1 (CB1) signaling diminishes with advancing age in specific brain regions that regulate learning and memory and abolishing CB1 receptor signaling accelerates cognitive aging in mice. We recently demonstrated that prolonged exposure to low dose (3 mg/kg/day) Δ
Identifiants
pubmed: 34526890
doi: 10.3389/fnagi.2021.718850
pmc: PMC8435893
doi:
Types de publication
Journal Article
Langues
eng
Pagination
718850Informations de copyright
Copyright © 2021 Nidadavolu, Bilkei-Gorzo, Krämer, Schürmann, Palmisano, Beins, Madea and Zimmer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur Neuropsychopharmacol. 2017 Dec;27(12):1223-1237
pubmed: 29129557
Nat Rev Neurosci. 2015 Dec;16(12):705-18
pubmed: 26585799
Nat Rev Neurosci. 2015 Jan;16(1):30-42
pubmed: 25524120
Neuron. 2017 Aug 30;95(5):1019-1035
pubmed: 28858613
Chem Biodivers. 2007 Aug;4(8):1770-804
pubmed: 17712819
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5193-8
pubmed: 23472002
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5780-5
pubmed: 10318961
Am J Med. 2019 Nov;132(11):1266-1270
pubmed: 31152723
J Alzheimers Dis. 2015;43(3):977-91
pubmed: 25125475
J Neurosci. 2016 Apr 13;36(15):4351-61
pubmed: 27076430
Pflugers Arch. 2016 Apr;468(4):727-37
pubmed: 26739712
Behav Pharmacol. 2016 Jun;27(4):393-6
pubmed: 26292188
Iran J Psychiatry. 2012 Fall;7(4):149-56
pubmed: 23408483
BMC Neurosci. 2012 Jul 24;13:87
pubmed: 22827915
Neurobiol Aging. 2001 Sep-Oct;22(5):787-96
pubmed: 11705638
Drug Alcohol Depend. 2017 Jun 1;175:187-197
pubmed: 28445853
Mech Ageing Dev. 2015 Sep;150:55-64
pubmed: 26278494
Br J Pharmacol. 2015 Oct;172(20):4790-805
pubmed: 26218440
Mol Pharmacol. 2018 Jul;94(1):743-748
pubmed: 29669714
Prog Chem Org Nat Prod. 2017;103:103-131
pubmed: 28120232
Curr Drug Metab. 2016;17(3):206-26
pubmed: 26651971
J Pain Symptom Manage. 2013 Aug;46(2):207-18
pubmed: 23141881
Acta Neurobiol Exp (Wars). 2018;78(1):41-50
pubmed: 29694340
Front Behav Neurosci. 2019 May 07;13:94
pubmed: 31133833
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
J Inflamm (Lond). 2018 Nov 16;15:23
pubmed: 30473634
Rev Neurosci. 2007;18(2):137-48
pubmed: 17593876
J Alzheimers Dis. 2016 Oct 4;54(3):903-912
pubmed: 27567873
Neuropsychopharmacology. 2010 Feb;35(3):764-74
pubmed: 19924114
Br J Pharmacol. 2009 Nov;158(5):1330-7
pubmed: 19681888
Neurobiol Aging. 2012 Jan;33(1):200.e11-22
pubmed: 20724033
Clin Geriatr Med. 2013 Nov;29(4):737-52
pubmed: 24094294
Drug Alcohol Depend. 2013 Dec 1;133(2):763-7
pubmed: 24018317
Front Neurosci. 2020 Dec 15;14:568200
pubmed: 33384577
Expert Opin Pharmacother. 2006 Apr;7(5):607-15
pubmed: 16553576
Development. 1998 Aug;125(16):3179-88
pubmed: 9671590
Drug Metab Dispos. 1995 Aug;23(8):825-31
pubmed: 7493549
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15670-5
pubmed: 16221768
Nat Med. 2017 Jun;23(6):782-787
pubmed: 28481360
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3017-22
pubmed: 21282661
Cannabis Cannabinoid Res. 2017 Sep 01;2(1):235-246
pubmed: 29098186
J Pain Symptom Manage. 2010 Feb;39(2):167-79
pubmed: 19896326
ILAR J. 2014;55(2):310-32
pubmed: 25225309
Naunyn Schmiedebergs Arch Pharmacol. 2016 Jun;389(6):603-12
pubmed: 26984820